-
Franciscan Health receives $30M donation for cancer center
Mishawaka, Ind.-based Franciscan Health Foundation received its largest gift ever, which will be used to create a new cancer center. -
States with the fewest oncologist per capita
Wyoming has the fewest active oncologists per capita, with eight oncologists in the state. -
Single CT scan increases blood cancer risk by 16%: Study
A recent study found that CT scans are linked to an increased risk of blood cancer in young people. -
Dana-Farber gets $72M donation
Boston-based Dana-Farber Cancer Institute received a $72 million donation from the Pan-Mass Challenge, an athletic fundraiser. -
MD Anderson to create 1st-of-its-kind oncology nursing institute
The University of Texas MD Anderson Cancer Center in Houston has received a $25 million gift from Howard Meyers to establish a first-of-its-kind institute for oncology nursing. -
RWJBarnabas Health, Rutgers Cancer Institute partner on care programs
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey are partnering on cancer care and research, including building three new facilities. -
19 recent cancer partnerships
Here are 19 recent cancer center partnerships: -
City of Hope taps new chief clinical officer
Duarte, Calif.-based City of Hope has selected Alan Bryce, MD, as the chief clinical officer of its Phoenix cancer center location, according to a Nov. 7 news release. -
10 states with most oncologists per capita
The District of Columbia has the highest number of active oncologists per capita. -
Moffitt researchers inch closer to vaccines that target solid tumors
Researchers from Tampa, Fla.-based Moffitt Cancer Center are investigating whether primary or metastatic tumors can be used to produce personalized neoantigen-targeted cancer vaccines. -
American Oncology Network to support patients with non-medical expenses
The American Oncology Network has launched a foundation to provide cancer patients with funding for non-medical related expenses, the organization announced Nov. 3. -
Genetic mutation diminishes drug response in some cancer patients
Researchers at Boston-based Mass General Brigham have discovered a key mutation that may be a driving factor in resistance to certain drugs used to treat breast cancer patients, according to a Nov. 2 news release. -
National Cancer Institute developing therapy to target solid tumors
Researchers at the National Cancer Institute may be inching closer to an improved type of T-cell therapy that could "supercharge" their response against solid tumors, according to a Nov. 1 news release. -
Lung cancer guidelines updated for 1st time in a decade
The American Cancer Society updated its lung cancer screening guidelines for the first time in a decade, with the goal of reducing deaths from disease due to smoking history. -
3 ways cancer care needs to change, per 8 leaders
Access to care, eliminating disparities and expanding quality care are the top three things leaders want changed about cancer care. -
FDA approves new head and neck cancer drug
The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients. -
Allina Health to test blood samples to catch cancer
Minneapolis-based Allina Health Cancer Institute is launching a first-of-its-kind clinical trial using artificial intelligence and a simple blood draw to find and diagnose cancer. -
Industry payments tied to low-value oncology care: Study
A study found oncologists who receive industry payments might be more likely to provide non-recommended and low-value treatment to cancer patients. -
Safety implications of USP 800 compliance in cancer care
Safe handling of chemotherapy drugs is challenging but essential for oncology centers -
Top oncology hospitals, per patients and providers
Fourteen hospitals and health systems were named elite choice oncology centers by patients and providers.
Page 10 of 50